[125I]IMPY	([125I]6-iodo-2-(40-dimethylamino)-phenyl-imidazo [1,2-a]pyridine)
ICP-MS	inductively coupled plasma mass spectrometry
[18F]FDDNP	(1,1-dicyanopropen-2-yl)-6-(2-[18F]-fluoroethyl)-methylamino-naphthalene
SPECT	single-photon emission computed tomography
PET	positron emission tomography
MRI	magnetic resonance imaging
AD	Alzheimer’s disease
BBB	Blood-brain barrier
CAA	cerebral amyloid angiopathy
PgP	P-glycoprotein
TEM	transmission electron microscopy
Tg-mice	transgenic mice
ThT	Thioflavin-T
DOTA	1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DO3A	1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
PCTA	3,6,9,15-tetraaza bicyclo[9.3.1]-pentadeca1(15),11,13-triene-3,6,9-triacetic acid
HBED-CC	N,N’-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N’-diacetic acid
NODAGA	1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid
AAZTA	1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)]amino-6-methylperhydro-1,4-diazepine
BAT-	Bis-amino bis-thiol
MAMA	Monoamine-monoamide dithiols
IC50	The half maximal inhibitory concentration
MTT	(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
PIB	2-(4′-[11C]methylaminophenyl)-6-hydroxybenzothiazole